Literature DB >> 9621286

Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites.

M Simon1, W Röckl, C Hornig, E F Gröne, H Theis, H A Weich, E Fuchs, A Yayon, H J Gröne.   

Abstract

Vascular endothelial growth factor (VEGF) has an important function in renal vascular ontogenesis and is constitutively expressed in podocytes of the adult kidney. The ability of VEGF to be chemotactic for monocytes and to increase the activity of collagenase and plasminogen activator may have implications for renal development and renal disease. In humans, the cellular actions of VEGF depend on binding to two specific receptors: Flt-1 and KDR. The aims of this study were: (1) to localize VEGF receptor proteins in human renal ontogenesis; (2) to quantify VEGF binding in human fetal and adult kidney; and (3) to dissect the binding into its two known components: the KDR and Flt-1 receptors. The latter aim was achieved by competitive binding of VEGF and placenta growth factor-2, which only binds to Flt-1. Quantification of 125I-VEGF binding sites was performed by autoradiography and computerized densitometry. By double-label immunohistochemistry, VEGF receptor proteins were localized solely to endothelial cells of preglomerular vessels, glomeruli, and postglomerular vessels. In developing glomeruli, VEGF receptor protein appeared as soon as endothelial cells were positive for von Willebrand factor. Specific 125I-VEGF binding could be localized to renal arteries and veins, glomeruli, and the tubulointerstitial capillary network in different developmental stages. Affinity (Kd) of adult (aK) and fetal (fK) kidneys was: Kd: glomeruli 38.6 +/- 11.2 (aK, n = 5), 36.3 +/- 7.1 (fK, n = 5); cortical tubulointerstitium 19.4 +/- 2.6 (aK, n = 5), 11.6 +/- 7.0 (fK, n = 5) pmol. Placenta growth factor-2 displaced VEGF binding in all renal structures by approximately 60%. VEGF receptor proteins thus were found only in renal endothelial cells. A coexpression of both VEGF binding sites could be shown, with Flt-1 demonstrating the most abundant VEGF receptor binding sites in the kidney. These studies support the hypothesis of a function for VEGF in adult kidney that is independent of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621286     DOI: 10.1681/ASN.V961032

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  29 in total

Review 1.  Protein-based tumor molecular imaging probes.

Authors:  Xin Lin; Jin Xie; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2010-03-17       Impact factor: 3.520

2.  Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.

Authors:  Shuei-Liong Lin; Fan-Chi Chang; Claudia Schrimpf; Yi-Ting Chen; Ching-Fang Wu; Vin-Cent Wu; Wen-Chih Chiang; Frank Kuhnert; Calvin J Kuo; Yung-Ming Chen; Kwan-Dun Wu; Tun-Jun Tsai; Jeremy S Duffield
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 3.  Unwrapping the origins and roles of the renal endothelium.

Authors:  Donna Beer Stolz; Sunder Sims-Lucas
Journal:  Pediatr Nephrol       Date:  2014-03-15       Impact factor: 3.714

4.  Regulator of Calcineurin 1 Isoform 4 (RCAN1.4) Is Overexpressed in the Glomeruli of Diabetic Mice.

Authors:  Chorong Jang; Ji Hee Lim; Cheol Whee Park; Young-Jin Cho
Journal:  Korean J Physiol Pharmacol       Date:  2011-10-31       Impact factor: 2.016

Review 5.  Development of the renal vasculature.

Authors:  Tahagod Mohamed; Maria Luisa S Sequeira-Lopez
Journal:  Semin Cell Dev Biol       Date:  2018-06-06       Impact factor: 7.727

6.  Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions.

Authors:  E Pillebout; M Burtin; H T Yuan; P Briand; A S Woolf; G Friedlander; F Terzi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

7.  Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.

Authors:  Y Masuda; A Shimizu; T Mori; T Ishiwata; H Kitamura; R Ohashi; M Ishizaki; G Asano; Y Sugisaki; N Yamanaka
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

8.  Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation.

Authors:  E Bailey; M J Bottomley; S Westwell; J H Pringle; P N Furness; J Feehally; P E Brenchley; S J Harper
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

Review 9.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

Review 10.  Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease.

Authors:  Omar C Logue; Jeremy W D McGowan; Eric M George; Gene L Bidwell
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-09       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.